These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Ethical issues in genome-era]. Kosugi S Nihon Rinsho; 2016 Jun; 74(6):1022-7. PubMed ID: 27311196 [TBL] [Abstract][Full Text] [Related]
4. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Green RC; Berg JS; Grody WW; Kalia SS; Korf BR; Martin CL; McGuire AL; Nussbaum RL; O'Daniel JM; Ormond KE; Rehm HL; Watson MS; Williams MS; Biesecker LG; Genet Med; 2013 Jul; 15(7):565-74. PubMed ID: 23788249 [TBL] [Abstract][Full Text] [Related]
5. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories. Ackerman SL; Koenig BA AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714 [TBL] [Abstract][Full Text] [Related]
6. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL; Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134 [No Abstract] [Full Text] [Related]
7. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL; Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242 [TBL] [Abstract][Full Text] [Related]
8. On the justifiability of ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. May T J Law Med Ethics; 2015; 43(1):134-42. PubMed ID: 25846044 [TBL] [Abstract][Full Text] [Related]
9. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Miller DT; Lee K; Gordon AS; Amendola LM; Adelman K; Bale SJ; Chung WK; Gollob MH; Harrison SM; Herman GE; Hershberger RE; Klein TE; McKelvey K; Richards CS; Vlangos CN; Stewart DR; Watson MS; Martin CL; Genet Med; 2021 Aug; 23(8):1391-1398. PubMed ID: 34012069 [No Abstract] [Full Text] [Related]
10. Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing. Allyse M; Michie M Trends Biotechnol; 2013 Aug; 31(8):439-41. PubMed ID: 23664778 [No Abstract] [Full Text] [Related]
11. Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization. Eno C; Bayrak-Toydemir P; Bean L; Braxton A; Chao EC; El-Khechen D; Esplin ED; Friedman B; Hagman KDF; Hambuch T; Hernandez A; Juusola J; Londre G; Machado J; Mao R; Mighion L; Rehm HL; Ward P; Deignan JL Genet Med; 2019 Apr; 21(4):861-866. PubMed ID: 30214068 [TBL] [Abstract][Full Text] [Related]
12. Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling. Smith LA; Douglas J; Braxton AA; Kramer K J Genet Couns; 2015 Aug; 24(4):654-62. PubMed ID: 25403901 [TBL] [Abstract][Full Text] [Related]
13. Distinguishing negligence from intentional tort when a health care provider deviates from a patient's consent. Cole CA; Holtz MD Med Staff Couns; 1993; 7(2):45-53. PubMed ID: 10124484 [TBL] [Abstract][Full Text] [Related]
14. Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review. Elfatih A; Mohammed I; Abdelrahman D; Mifsud B Physiol Genomics; 2021 Sep; 53(9):373-384. PubMed ID: 34250816 [TBL] [Abstract][Full Text] [Related]
15. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360 [TBL] [Abstract][Full Text] [Related]
16. From Genetics to Genomics: Facing the Liability Implications in Clinical Care. Marchant G; Barnes M; Evans JP; LeRoy B; Wolf SM; J Law Med Ethics; 2020 Mar; 48(1):11-43. PubMed ID: 32342786 [TBL] [Abstract][Full Text] [Related]
17. Medicolegal implications of colon cancer screening. Feld AD Gastrointest Endosc Clin N Am; 2002 Jan; 12(1):171-9, viii-ix. PubMed ID: 11916158 [TBL] [Abstract][Full Text] [Related]
18. Recommendations for returning genomic incidental findings? We need to talk! Burke W; Antommaria AH; Bennett R; Botkin J; Clayton EW; Henderson GE; Holm IA; Jarvik GP; Khoury MJ; Knoppers BM; Press NA; Ross LF; Rothstein MA; Saal H; Uhlmann WR; Wilfond B; Wolf SM; Zimmern R Genet Med; 2013 Nov; 15(11):854-9. PubMed ID: 23907645 [TBL] [Abstract][Full Text] [Related]
19. Intentional torts claims in medical cases. Cockburn T; Madden B J Law Med; 2006 Feb; 13(3):311-35. PubMed ID: 16506725 [TBL] [Abstract][Full Text] [Related]